Avalyn Pharma Inc. · NASDAQ:AVLN
Lazarus Howard sold 13,300 Avalyn Pharma Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Lazarus Howard (Chief Medical Officer) sold 13,300 Avalyn Pharma Inc. shares at an average US$27.90 for US$371K under a trading plan, leaving 0 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 13,300 shares
- Price
- US$27.90 average (US$27.80 to US$29.27)
- Value
- US$371K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Option exercise | 13,300 | US$4.62 | 13,300 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 11,023 | US$27.80 | 2,277 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 2,066 | US$28.27 | 211 | Direct |
| Nov 17, 2026 | Common Stock | Sale | 211 | US$29.27 | 0 | Direct |
Source
Download original · View original at SEC